Study of NTX-1472 for social anxiety disorder
Part of Mental health clinical trials.
This trial tests an investigational medicine called NTX-1472 to see if it helps people with social anxiety disorder. Participation involves taking the study drug and attending scheduled visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a diagnosis of generalized social anxiety disorder (not just performance anxiety).
- Your social anxiety symptoms must be at least moderately severe based on a standard rating scale.
- You cannot have major depression, bipolar disorder, OCD, PTSD, or other serious mental health conditions.
- You must not be taking daily psychiatric medications within 4 weeks of starting the study.
- If you can become pregnant, you must agree to use effective birth control during the study and for 2 weeks after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a non-invasive brain stimulation technique called theta burst stimulation can help treat social anxiety disorder. It uses magnetic pulses to target a brain area involved in fear and anxiety, and you may benefit if you have social anxiety and are not taking certain medications.
This study is testing a computer-based treatment for social anxiety disorder. It may help reduce anxiety in social situations through a structured online program, and it also includes brain imaging (MRI) to see how the treatment affects the brain.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study uses brain recordings (EEG and MRI) to understand how treatments help people with social anxiety. It also looks for signals that may predict who is most likely to benefit from treatment.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
Hear when a new Social Anxiety Disorder (SAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.